Immunological Medicines for Pigs
Immunological veterinary medicinal products, including vaccines, are authorised for pigs.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
Porcilis M Hyo ID ONCE
|
Enzootische Pneumonie
|
Intervet Deutschland GmbH
|
PEI.V.11476.01.1 |
14.11.2011 |
Mastschwein, Schwein |
PharmNet.Bund
|
Porcilis Begonia Unisolve
|
Aujeszky'sche Krankheit
|
Intervet Deutschland GmbH
|
53a/95 |
02.05.1995 |
Schwein |
PharmNet.Bund
|
Porcilis Parvo
|
Parvovirose
|
Intervet Deutschland GmbH
|
211a/94 |
04.11.1998 |
Schwein |
PharmNet.Bund
|
Decivac FMD DOE
|
Maul- und Klauenseuche
|
Intervet Deutschland GmbH
|
BFAV-MKS/2/2000 |
31.07.2000 |
Rind, Schaf, Schwein, Ziege |
PharmNet.Bund
|
Porcilis PCV
|
Circovirus-Infektion
|
Intervet International B.V., Niederlande
|
EU/2/08/091/001-010 |
12.01.2009 |
Schwein |
EPAR: Porcilis PCV
|
Porcilis PCV M Hyo
|
Circovirus-Infektion, Enzootische Pneumonie
|
Intervet International B.V., Niederlande
|
EU/2/14/175/001-010 |
07.11.2014 |
Schwein |
EPAR: Porcilis PCV M Hyo
|
Porcilis PCV ID
|
Circovirus-Infektion
|
Intervet International B.V., Niederlande
|
EU/2/15/187/001-004 |
28.08.2015 |
Schwein |
EPAR: Porcilis PCV ID
|
Porcilis PCV M Hyo ID
|
Circovirus-Infektion, Enzootische Pneumonie
|
Intervet International B.V., Niederlande
|
EU/2/24/319 |
02.09.2024 |
Schwein |
EPAR: Porcilis PCV M Hyo ID
|
Porcilis AR-T DF
|
Rhinitis atrophicans
|
Intervet International BV, Niederlande
|
EU/2/00/026/001-006 |
20.11.2000 |
Schwein |
EPAR: Porcilis AR-T DF
|
Porcilis ColiClos
|
E. coli-Infektion,
Clostridien-Infektion
|
Intervet International BV, Niederlande
|
EU/2/12/141/001-009 |
17.06.2012 |
Schwein |
EPAR: Porcilis ColiClos
|
Porcilis Porcoli Diluvac Forte
|
E. coli-Ferkelenteritis
|
Intervet International BV, Niederlande
|
EU/2/96/001/003-008 |
22.05.2002 |
Schwein |
EPAR: Porcilis Porcoli Diluvac Forte
|
FIXR PRRS inac
|
PRRS
|
Kernfarm B.V., Niederlande
|
PEI.V.12231.01.1 |
25.02.2025 |
Schwein |
PharmNet.Bund
|
UNISTRAIN PRRS
|
PRRS
|
Laboratorios Hipra S.A., Spanien
|
PEI.V.11596.01.1 |
13.03.2013 |
Schwein |
PharmNet.Bund
|
Suiseng Coli / C
|
E. coli-Infektion, Clostridien-Infektion
|
Laboratorios Hipra S.A., Spanien
|
PEI.V.12026.01.1 |
01.04.2020 |
Schwein |
PharmNet.Bund
|
Eryseng Parvo
|
Rotlauf, Parvovirose
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/14/167/001-007 |
08.07.2014 |
Schwein |
EPAR: Eryseng Parvo
|
Suiseng
|
E. coli-Enterotoxikose, Nekrotisierende Enteritis, Clostridien-Infektion
|
Laboratorios Hipra, S.A., Spanien
|
PEI.V.04349.01.1 |
07.09.2009 |
Schwein |
PharmNet.Bund
|
Eryseng
|
Rotlauf
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/14/166/001-007 |
04.07.2014 |
Schwein |
EPAR: Eryseng
|
MYPRAVAC SUIS
|
Enzootische Pneumonie
|
Laboratorios Hipra, S.A., Spanien
|
PEI.V.02850.01.1 |
12.06.2003 |
Schwein |
PharmNet.Bund
|
Rhiniseng
|
Rhinitis atrophicans
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/10/109/001-009 |
16.09.2010 |
Schwein |
EPAR: Rhiniseng
|
MHYOSPHERE PCV ID
|
Circovirus-Infektion, Mykoplasmen-Infektion
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/20/259 |
18.09.2020 |
Schwein |
EPAR: MHYOSPHERE PCV ID
|
VEPURED
|
Ödemkrankheit
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/17/214/001-005 |
17.08.2017 |
Schwein |
EPAR: VEPURED
|
Suiseng Diff/A
|
Clostridien-Infektion (Clostridioides difficile, Clostridium perfringens)
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/21/278 |
07.12.2021 |
Schwein |
EPAR: Suiseng Diff/A
|
Syvac Ery Parvo
|
Parvovirose, Rotlauf
|
Laboratorios Syva, S.A., Spanien
|
PEI.V.12131.01.1 |
21.09.2022 |
Schwein |
|
Ingelvac Ery
|
Rotlauf
|
Laboratorios Syva, S.A.U., Spanien
|
PEI.V.12041.01.1 |
30.04.2021 |
Schwein |
PharmNet.Bund
|
Suigen Rota Coli
|
E. coli-Infektion, Rotavirus-Infektion
|
Virbac S.A., Frankreich
|
PEI.V.12117.01.1 |
13.06.2021 |
Schwein |
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.